Netherlands Cancer Institute
OVERVIEW
The Netherlands Cancer Institute (NKI) is the main research and hospital centre focused on tumours in the Netherlands. It was founded in Amsterdam in 1913 and was a pioneer in the study of cancer from a genetic perspective since the 1980s. Current areas of study include image-guided therapy, immunotherapy, precision oncology, and cancer early detection.
This resource is also mentioned here:
Key Players
Contributions
-
Molecular classification of breast cancer, an unfinished story
-
Platinum chemotherapy: a mainstay in drug treatment - Carboplatin